Table 4.

Relation between miRs and demographic, clinical and pathologic findings in both groups

		miR-222		miR-181a		miR-155-5-P		miR-146a
		Pre-op	Post-op	Pre-op	Post-op	Pre-op	Post-op	Pre-op	Post-op
Age	Case	0.95	0.96	0.20	0.46	0.32	0.28	0.41	0.60
	Control	0.67	0.10	0.01	0.05	0.60	0.67	0.43	0.41
Lymphadenectomy	Case	0.25	0.10	0.42	0.46	0.30	0.24	0.28	0.14
	Control
Lymph node involvement	Case	0.24	0.31	0.59	0.28	0.50	0.45	0.32	0.09
	Control
Sex	Case	0.03	0.46	0.006	0.12	0.42	0.50	0.20	0.16
	Control	0.18	0.41	0.08	0.05	0.39	0.32	0.27	0.49
Size	Case	0.95		0.04		0.38		0.78
	Control	0.32		0.65		0.13		0.14
BRAFV600E	Case	< 0.001	0.98	0.60	0.64	0.30	0.30	< 0.001	< 0.001
	Control	0.22	0.86	0.60	0.52	0.32	0.32	0.18	0.18
Capsular involvement	Case	0.15	0.66	0.09	0.83	0.11	0.11	0.71	0.80
	Control	0.27	0.13	0.26	0.24	0.59	0.52	0.04	0.01
Involved lobe of thyroid	Case	0.66	0.28	0.71	0.36	0.47	0.47	0.57	0.62
	Control	0.72	0.45	0.87	0.02	0.43	0.40	0.96	0.87

All P-values were obtained by Mann-Whitney U test, whereas the significant findings are italic